EUVIMEDEUVIMED entdecken
Crossref

Utilization Rates of Beneficial and Potentially Harmful Medications in the Outpatient Management of Chronic Kidney Disease

Andrea Callas, Kelsey Buckley, Nicole K Early, Kathleen A Fairman

The Senior Care Pharmacist · 2025

DOI: 10.4140/tcp.n.2025.255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Senior Care Pharmacist, 2025. Verfasst von Andrea Callas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Midwestern University College of Pharmacy, Glendale Campus, Glendale, Arizona. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Nonprescription Drugs, Ambulatory Care, Practice Patterns, Physicians'. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An estimated 14% of U.S. adults are affected by CKD, of whom about 34% are aged 65 years or older. Certain prescribed or over-the-counter medications can exacerbate or help slow CKD progression.

Objective

To evaluate prescriptions or recommendations for potentially beneficial and harmful medications in patients with CKD.

Design

Retrospective, cross-sectional analysis of medical records from U.S. office-based physician visits.

Setting

National Ambulatory Medical Care Survey, visits made by patients with CKD, 2014-2019.

Interventions

Comparison of rates and predictors for potentially beneficial versus potentially harmful medications including both prescribed and recommended over-the-counter agents.

Methods

CKD and related comorbidities were identified using indicators collected from the record regardless of the reason for the sampled visit. Medication classification was based on current guidelines and studies. Analyses included descriptive statistics of patient characteristics and predictors of beneficial versus harmful medication prescriptions/ recommendations.

Results

A total of 2,805 adult patients with a diagnosis of CKD were sampled. A plurality were aged 75 years or older (47.4%); majorities were White non-Hispanic (64.0%) with comorbid hypertension (78.8%). Beneficial medications only were prescribed/ recommended to 12.2% of patients, harmful medications only to 20.6%, a mix of beneficial/ harmful medications to 26.7%, and neither to 40.5%. Strong positive predictors of potentially harmful medication prescriptions/recommendations included polypharmacy and diagnoses of cerebrovascular disease or congestive heart failure.

Discussion

Prescribing patterns for patients with CKD highlight the importance of medication optimization to balance therapeutic benefits and harms.

Conclusion

Pharmacists can educate providers to improve prescribing practices in patients with CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicNonprescription DrugsAmbulatory CarePractice Patterns, Physicians'HumansAgedCross-Sectional StudiesMaleFemaleRetrospective StudiesAged, 80 and overMiddle AgedUnited StatesOutpatientsAdultPrescription Drugs

Substanzen

Nonprescription DrugsPrescription Drugs

Autor:innen und Institutionen

  • Midwestern University College of Pharmacy, Glendale Campus, Glendale, Arizona.

Zitieren

APA

Callas, A., Buckley, K., Early, N. K., & Fairman, K. A. (2025). Utilization Rates of Beneficial and Potentially Harmful Medications in the Outpatient Management of Chronic Kidney Disease. The Senior Care Pharmacist. https://doi.org/10.4140/tcp.n.2025.255

Vancouver

Callas A, Buckley K, Early NK, Fairman KA. Utilization Rates of Beneficial and Potentially Harmful Medications in the Outpatient Management of Chronic Kidney Disease. The Senior Care Pharmacist. 2025. doi:10.4140/tcp.n.2025.255

BibTeX
@article{Callas2025,
  author = {Callas, Andrea and Buckley, Kelsey and Early, Nicole K and Fairman, Kathleen A},
  title = {Utilization Rates of Beneficial and Potentially Harmful Medications in the Outpatient Management of Chronic Kidney Disease},
  journal = {The Senior Care Pharmacist},
  year = {2025},
  doi = {10.4140/tcp.n.2025.255}
}
Kostenlos starten →